Literature DB >> 10027203

Chemoprevention of colorectal cancer: dietary and pharmacologic approaches.

C A Garay1, P F Engstrom.   

Abstract

Colorectal cancer is a major cause of death in the United States, where it accounts for approximately 57,000 deaths per year. Thus, the prevention of this disease would have a significant impact on public health. Chemoprevention is defined as the use of natural or pharmacologic agents to disrupt the process of carcinogenesis. Substances explored as chemopreventive agents in colorectal cancer include: (1) the nonsteroidal anti-inflammatory drugs (NSAIDS), which may inhibit the evolution and formation of adenomas by their inhibition of cyclooxygenase and decrease of prostaglandin synthesis; (2) antioxidants, such as vitamin E or C, which may modulate carcinogenic substances; and (3) folate and calcium, which may interfere with tumor cell growth and replication. Dietary intervention can be accomplished by decreasing fat intake and increasing fiber consumption, both of which have been linked to a lower incidence of colon cancer in multiple epidemiologic studies. This field is continuing to evolve. Hopefully, ongoing research efforts will offer a better understanding of the role of these and other substances in chemoprevention. This article summarizes the available data regarding dietary and pharmacologic approaches to colorectal cancer chemoprevention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027203

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  4 in total

1.  Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours.

Authors:  Tae Jung Jang; Ho Guen Jung; Ki Hoon Jung; Min Ku O
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

Review 2.  Nonsteroidal anti-inflammatory drugs and prevention of colorectal cancer.

Authors:  N Arber; R N DuBois
Journal:  Curr Gastroenterol Rep       Date:  1999-10

3.  6,7,4'-trihydroxyisoflavone inhibits HCT-116 human colon cancer cell proliferation by targeting CDK1 and CDK2.

Authors:  Dong Eun Lee; Ki Won Lee; Sung Keun Jung; Eun Jung Lee; Jung A Hwang; Tae-Gyu Lim; Bo Yeon Kim; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  Carcinogenesis       Date:  2011-01-21       Impact factor: 4.944

4.  A novel synthetic ursolic acid derivative inhibits growth and induces apoptosis in breast cancer cell lines.

Authors:  Wei Li; Hongxiu Zhang; Mingxiu Nie; Wei Wang; Zongtao Liu; Ceshi Chen; Haijun Chen; Rong Liu; Zulqarnain Baloch; Ke Ma
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.